Evidence map›Paper›PMID 40456953›Full record

ReviewMolecular psychiatry2025

Practical AI application in psychiatry: historical review and future directions.

Jie Sun, Tangsheng Lu, Xuexiao Shao, Ying Han, Yu Xia, Yongbo Zheng, Yongxiang Wang, Xinmin Li, Arun Ravindran, Lizhou Fan and 6 more

Abstract readReview
In one paragraph

Review in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Unmet needs in functional neurological disorder related to digital healthcare.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Precision medicine in mental health: applications, challenges, and recommendations.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jie Sun *Pain Medicine Center, Peking University Third Hospital, Peking University, Beijing, 100191, China.
Tangsheng Lu *National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China.
Xuexiao ShaoInstitute of Brain Science and Brain-inspired Research, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China.
Ying HanNational Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China.ORCID 0000-0002-8381-4071
Yu XiaSchool of Basic Medical Sciences, Peking University, Beijing, 100871, China.
Yongbo ZhengPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, 100191, China.ORCID 0000-0002-5314-5364
Yongxiang WangInstitute of Brain Science and Brain-inspired Research, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China.
Xinmin LiDepartment of Psychiatry, Faculty of Medicine, 1E1 Walter Mackenzie Health Sciences Centre, University of Alberta, Edmonton, AB, T6G 2B7, Canada.
Arun RavindranInstitute of Medical Science, Toronto, ON, M5S 1A8, Canada.ORCID 0000-0002-1655-2753
Lizhou FanArtificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0002-7962-9113
Yin FangNorth China University of Science and Technology, Tangshan, Hebei, 063210, China.
Xiujun ZhangNorth China University of Science and Technology, Tangshan, Hebei, 063210, China.
Nisha RavindranInstitute of Medical Science, Toronto, ON, M5S 1A8, Canada.ORCID 0000-0002-0468-1099
Yumei WangInstitute of Brain Science and Brain-inspired Research, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China. wangyumei19771021@hotmail.com.
Xiaoxing LiuPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, 100191, China. liuxiaoxing@pku.edu.cn.ORCID 0000-0001-7592-0483
Lin LuPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, 100191, China. linlu@bjmu.edu.cn.ORCID 0000-0003-0742-9072

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82201644National Natural Science Foundation of China (National Science Foundation of China) 82471505
6 · The paper itself

Abstract

The integration of artificial intelligence (AI) in mental healthcare holds promise for enhancing diagnostic precision, treatment efficacy, and personalized care. Despite AI's potential to analyze vast datasets and identify subtle patterns, its clinical adoption in psychiatry remains limited. This review critically examines the emerging role of AI in psychiatry, elucidating its utility, challenges, and implications for clinical practice. Through an extensive analysis of the existing literature and empirical evidence, we seek to inform psychiatric stakeholders about both opportunities and obstacles that are presented by AI. We evaluate AI's potential to improve diagnostic accuracy, prognostic performance, and therapeutic interventions. Our pragmatic approach bridges the gap between theoretical advancements and practical implementation, providing valuable insights and actionable recommendations for psychiatric professionals. This article highlights the supportive role of AI, advocating for its judicious integration to enhance patient outcomes while maintaining the human-centric essence of psychiatric practice. By addressing these challenges and fostering collaboration, AI can significantly advance mental healthcare, reduce clinical burdens, and improve patient outcomes.

Indexed as

Artificial IntelligencePsychiatryHumansMental DisordersPrecision Medicine

Identifiers

PMID40456953
PMCPMC12339366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.